ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer
نویسندگان
چکیده
Summary This article intends to summarize personal non-small cell lung cancer (NSCLC) highlights of the virtual ASCO 2021 meeting. Immunotherapy is now a mainstay advanced stage NSCLC treatment and there are several ongoing studies investigating role immunotherapy in early NSCLC. At first data on atezolizumab adjuvant setting were presented give positive signal that will also become an option for patient Furthermore, overall survival (OS) updates two effects epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) EGFR-mutated patients presented. In conclusion provided community with inspiring new especial stages challenges integration these into our daily clinical routine.
منابع مشابه
Survival in untreated early stage non-small cell lung cancer.
BACKGROUND The aim of this study was to determine the survival of untreated stage I and II in non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS A retrospective analysis of medical charts of all patients diagnosed with early stage NSCLC, between January 1990 and December 2001, was conducted and patients who were not treated were identified. Data on patient's age, gender, stage ...
متن کاملTreatment of early stage non-small cell lung cancer.
Photodynamic therapy (PDT), brachytherapy, electrocautery, cryotherapy, and Nd-YAG laser therapy are therapeutic options available for management of endobronchial malignancies. All of these treatment modalities have been used for both palliation of late obstructing cancers, and more recently have been used as primary treatment of early radiographically occult cancers. We reviewed the evidence f...
متن کاملMethylation Markers of Early-Stage Non-Small Cell Lung Cancer
BACKGROUND Despite of intense research in early cancer detection, there is a lack of biomarkers for the reliable detection of malignant tumors, including non-small cell lung cancer (NSCLC). DNA methylation changes are common and relatively stable in various types of cancers, and may be used as diagnostic or prognostic biomarkers. METHODS We performed DNA methylation profiling of samples from ...
متن کاملSurgical treatment of early-stage non-small-cell lung cancer
Surgical resection remains the standard of care for functionally operable early-stage non-small-cell lung cancer (NSCLC) and resectable stage IIIA disease. The role of invasive staging and restaging techniques is currently being debated, but they provide the largest biopsy samples which allow for precise mediastinal staging. Different types of operative procedures are currently available to the...
متن کاملAdjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related mortality in the developed world. Non-small cell lung cancer (NSCLC) represents 85% of cases of lung cancer, and patients have a poor 5-year survival rate. Approximately one third of NSCLC patients present with early-stage disease that is amenable to potentially curative resection and multimodality therapy. Several randomized trials now have co...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Memo – Magazine of European Medical Oncology
سال: 2021
ISSN: ['1865-5041', '1865-5076']
DOI: https://doi.org/10.1007/s12254-021-00770-w